Institutions / Barclays PLC / Activity
Activity — Barclays PLC
49,937 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q4 2023 as of | Trim | L0423Q124 Common stock | $-1 | -1 -0.20% | 501 0.00% of portfolio | low |
| Q3 2023 as of | Add | L0423Q124 Common stock | $1 | +1 +0.20% | 502 0.00% of portfolio | low |
| Q4 2023 as of | Add | 68620P705 Common stock | $1 | +1 +<0.01% | 11,476 <0.01% of portfolio | low |
| Q1 2025 as of | Add | 00653A107 Common stock | $1 | +7 +0.01% | 50,068 <0.01% of portfolio | low |
| Q1 2025 as of | Trim | 81750R102 Common stock | $-1 | -2 -0.13% | 1,593 0.00% of portfolio | low |
| Q1 2025 as of | Add | 80880W106 Common stock | $2 | +8 +<0.01% | 195,473 <0.01% of portfolio | low |
| Q3 2025 as of | Exit | 86745K104 Common stock | $-2 | -4K -100.00% | 0 | low |
| Q2 2023 as of | Exit | 54911Q107 Common stock | $-2 | -96 -100.00% | 0 | low |
| Q2 2025 as of | Exit | 89458T205 Common stock | $-2 | -27 -100.00% | 0 | low |
| Q1 2025 as of | New | 89458T205 Common stock | $2 | +27 | 27 0.00% of portfolio | low |
| Q1 2025 as of | New | 09077B104 Common stock | $2 | +6 | 6 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 01671P100 Common stock | $-2 | -11 -100.00% | 0 | low |
| Q2 2025 as of | Exit | 654110303 Common stock | $-2 | -11 -100.00% | 0 | low |
| Q2 2025 as of | Exit | 09077B104 Common stock | $-2 | -6 -100.00% | 0 | low |
| Q4 2025 as of | Exit | Curis, Inc. Common stock | $-2 | -1 -100.00% | 0 | low |
| Q1 2025 as of | New | 08178Q309 Common stock | $2 | +5 | 5 0.00% of portfolio | low |
| Q2 2025 as of | Exit | Spectral AI, Inc. Common stock | $-2 | -2 -100.00% | 0 | low |
| Q1 2025 as of | New | Curis, Inc. Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 08178Q309 Common stock | $-2 | -5 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 87166L209 Common stock | $-2 | -1 -100.00% | 0 | low |
| Q1 2025 as of | New | 98138J404 Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | RFL Rafael Holdings, Inc. Common Stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | Minerva Neurosciences, Inc. Common stock | $-2 | -1 -100.00% | 0 | low |
| Q1 2025 as of | New | Spectral AI, Inc. Common stock | $2 | +2 | 2 0.00% of portfolio | low |
| Q1 2025 as of | New | 042255109 Common stock | $2 | +2 | 2 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 054754858 Common stock | $-2 | -1 -100.00% | 0 | low |
| Q4 2024 as of | Exit | SHIM Shimmick Corp Common Stock | $-2 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | SHIM Shimmick Corp Common Stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | PROK Prokidney Corp. Common Stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | 87166L209 Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | Minerva Neurosciences, Inc. Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | Exit | 62526P406 Common stock | $-2 | -1 -100.00% | 0 | low |
| Q3 2023 as of | Exit | 36850R204 Common stock | $-2 | -52 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 60783X104 Common stock | $-3 | -14 -100.00% | 0 | low |
| Q1 2025 as of | New | 08862L103 Common stock | $3 | +11 | 11 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 08862L103 Common stock | $-3 | -11 -100.00% | 0 | low |
| Q4 2025 as of | New | 88831L202 Common stock | $3 | +1 | 1 0.00% of portfolio | low |
| Q2 2025 as of | Exit | VVOS Vivos Therapeutics, Inc. Common Stock | $-3 | -1 -100.00% | 0 | low |
| Q2 2025 as of | Exit | ANVS Annovis Bio, Inc. Common Stock | $-3 | -2 -100.00% | 0 | low |
| Q1 2025 as of | New | VVOS Vivos Therapeutics, Inc. Common Stock | $3 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 185064102 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q1 2025 as of | New | ANVS Annovis Bio, Inc. Common Stock | $3 | +2 | 2 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 25461T105 Common stock | $-3 | -4 -100.00% | 0 | low |
| Q1 2025 as of | New | VTGN Vistagen Therapeutics, Inc. Common Stock | $3 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 25461T105 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q3 2023 as of | Exit | 55003A108 Common stock | $-3 | -1 -100.00% | 0 | low |
| Q2 2023 as of | Exit | 89532E208 Common stock | $-3 | -4 -100.00% | 0 | low |
| Q4 2025 as of | New | 20678X403 Common stock | $3 | +2 | 2 0.00% of portfolio | low |
| Q1 2023 as of | New | 89532E208 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q4 2025 as of | Trim | 00507W206 Common stock | $-3 | -3 -75.00% | 1 0.00% of portfolio | low |